EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Stage‐Dependent Roles of PANoptosis in MASLD: From Isolated Steatosis to Hepatocellular Carcinoma

Yuqin Zhao, Rui Wang, Qing Liu, Miao Tian, Meiqi Zhang, Peng Tang, Haoyi Wang, Jing Yang

Cell Biochemistry and Function · 2026-11 · 44 (11)

DOI: 10.1002/cbf.70340 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Biochemistry and Function, online erschienen am 17.11.2026. Verfasst von Yuqin Zhao und 7 weiteren Autor:innen. Die Arbeit nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PANoptosis is an inflammatory form of programmed cell death mediated by PANoptosome complexes that integrate the key features of apoptosis, pyroptosis, and necroptosis. Although PANoptosis has been increasingly implicated in liver injury, inflammation, and tumor immunity, its stage‐dependent roles across the full spectrum of metabolic dysfunction‐associated steatotic liver disease (MASLD), from isolated steatosis to hepatocellular carcinoma (HCC), remain incompletely defined. This review summarizes the molecular mechanisms of PANoptosis and discusses its dynamic evolution during MASLD progression. In isolated steatosis, PANoptosis‐related signaling may remain in a sublethal activation state, contributing to early stress responses without extensive inflammatory cell death. During progression to metabolic dysfunction‐associated steatohepatitis (MASH) and liver fibrosis, metabolic, immune, and structural insults may synergistically amplify PANoptosis‐related inflammatory cell death, thereby promoting hepatocyte injury, inflammatory amplification, and fibrogenesis. In HCC, PANoptosis may exert context‐dependent dual effects: acute and robust activation in tumor cells may enhance immunogenic cell death and antitumor immunity, whereas chronic or excessive activation in the liver microenvironment may sustain inflammation, immune suppression, and tumor progression. These stage‐specific features suggest that PANoptosis‐related molecules may serve as candidate biomarkers and therapeutic targets for MASLD stratification and precision treatment. Rather than simply inhibiting or inducing PANoptosis, future strategies should aim to modulate the intensity, duration, and cellular specificity of PANoptosis activation. By integrating mechanistic evidence with translational perspectives, this review proposes a stage‐dependent framework for understanding PANoptosis in the MASLD‐HCC continuum.

Zitieren

APA

Zhao, Y., Wang, R., Liu, Q., Tian, M., Zhang, M., Tang, P., Wang, H., & Yang, J. (2026). Stage‐Dependent Roles of PANoptosis in MASLD: From Isolated Steatosis to Hepatocellular Carcinoma. Cell Biochemistry and Function, 44(11). https://doi.org/10.1002/cbf.70340

Vancouver

Zhao Y, Wang R, Liu Q, Tian M, Zhang M, Tang P, et al. Stage‐Dependent Roles of PANoptosis in MASLD: From Isolated Steatosis to Hepatocellular Carcinoma. Cell Biochemistry and Function. 2026;44(11). doi:10.1002/cbf.70340

BibTeX
@article{Zhao2026,
  author = {Zhao, Yuqin and Wang, Rui and Liu, Qing and Tian, Miao and Zhang, Meiqi and Tang, Peng and Wang, Haoyi and Yang, Jing},
  title = {Stage‐Dependent Roles of PANoptosis in MASLD: From Isolated Steatosis to Hepatocellular Carcinoma},
  journal = {Cell Biochemistry and Function},
  year = {2026},
  volume = {44},
  number = {11},
  doi = {10.1002/cbf.70340}
}
Kostenlos starten →